asthma drug

Global Asthma Drugs Market Forecast to 2028

Global Asthma Drugs Market Forecast to 2028

Dublin, June 21, 2022 (GLOBE NEWSWIRE) — The “Global Asthma Drugs Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Medications, Route of Administration, and Distribution Channels” report has been added to ResearchAndMarkets.com’s offering. The asthma drugs market is projected to reach US$34,136.10 million in 2028 from US$24,239.17 million in 2021; it is …

Global Asthma Drugs Market Forecast to 2028 Read More »

Glenmark drug for treating uncontrolled asthma gets Indian regulator’s nod

Glenmark drug for treating uncontrolled asthma gets Indian regulator’s nod

Mumbai-based Glenmark has got the Indian regulator’s approval for a drug to treat patients of uncontrolled asthma. The fixed dose combination (FDC) drug will be sold under the brand name Indamet. An FDC drug combines two or more active ingredients into a single pill in a fixed dosage ratio. Indamet–a combination of Indacaterol and Mometasone–will …

Glenmark drug for treating uncontrolled asthma gets Indian regulator’s nod Read More »